Denali Therapeutics Inc. (DNLI) Shareholder/Analyst Call Transcript

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Rising Alzheimer’s rates prompt federal aid and new scientific findings on disease prevention and detection

WEST MONROE, La. (KTVE/KARD) – According to the National Institute on Aging, 6.9 million Americans are living with ...
News Medical on MSN

Study offers hope of preventing hydrocephalus in children

Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it ...
Le Lézard

Alzheon Reports Plasma Biomarker Results from Phase 3 and 2 Studies of Valiltramiprosate/ALZ-801, Validating Its First-in-Class Mechanism of Action and Underscoring Benefits in ...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with Alzheimer's disease (AD) and other ...
Kaleido Scope

IDEA Course Evaluations

The evaluation offers two survey types, Diagnostic and Learning Essentials, tailored to align with course objectives and provide meaningful insights. At UAB, we use Anthology Evaluate as the platform ...